INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,213 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
LS
Leibowitz Arthur SDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
Page 1239 of 1756
← PrevNext →
traded Feb 18, 2026
+2d
SEC Form 4

Evidence

17
GL
Giacomin Jon LDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
GS
Gillheeney Gary S.Director, President and CEO
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
890.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
SC
Siatis Perry CEVP, GC AND SECRETARY
ABBVAbbVie Inc.
Grant or award
A—
5,792 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
DP
Duraibabu PrathyushaDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
QG
Quintero GilbertoDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
CB
Cook Gregory BEVP & PRES - INST GROUP
ECLECOLAB INC.
Grant or award
A—
3,388 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
RP
Richer Tobin PEVP Marketing & Communications
KAROPENLANE, Inc.
Grant or award
A—
6,787 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
KK
Kuppusamy KarthikSVP, Clinical Solutions
DGXQUEST DIAGNOSTICS INC
Grant or award
A—
2,135 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
AJ
Alfano Nicholas J.EVP & PRES - GLOBAL WATER
ECLECOLAB INC.
Grant or award
A—
2,202 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
40.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
WR
Webb Michael ReedSVP & Chief Admin Officer
ROGROGERS CORP
Grant or award
A—
3,451 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
ZE
Zitting Shaun EllenChief Human Resources Officer
NIQNIQ Global Intelligence plc
Grant or award
A—
39.5K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
EJ
Eelman Anthony J.EVP, Chief Products Officer
AMTBAmerant Bancorp Inc.
Option exercise
M—
333 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
RP
Rivard PhilipSR VP Business Development
WCNWaste Connections, Inc.
Option exercise
M—
640 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
FL
Freedman LoriChief Admin. and Legal Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
203.1K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
210.9K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
234.4K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

17
DJ
Driscoll Michael JosephDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

16
RP
Richer Tobin PEVP Marketing & Communications
KAROPENLANE, Inc.
Tax withholding
F$64K
2,203 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

16
CL
Conley Trisha LEVP, People and Culture
LYBLyondellBasell Industries N.V.
Grant or award
A$112K
2,004 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

16
DE
Deitzel EdwardEVP, CRO, CCO MIAX Exchanges
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Tax withholding
F$247K
6,035 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

15
SJ
Slattery Paul JosephGENERAL COUNSEL & SECRETARY
BSLKBolt Projects Holdings, Inc.
Grant or award
A—
21.1K sh
Feb 9, 2026Feb 20, 2026
traded Feb 9, 2026
+11dSEC Form 4

Evidence

15
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$300K
45.1K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

15
SA
Seda Ivan AEVP, Chief Financial Officer
COLBCOLUMBIA BANKING SYSTEM, INC.
Grant or award
A$400K
12.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

15
JA
Jain AshishChief Technology Officer
OSPNOneSpan Inc.
Grant or award
A—
31.9K sh
Feb 17, 2026Feb 20, 2026
traded Feb 17, 2026
+3dSEC Form 4

Evidence

15
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Small acquisition
L$2,753
15 sh
Jan 28, 2026Feb 20, 2026
traded Jan 28, 2026
+23dSEC Form 4

Evidence

15
GS
Gillheeney Gary S.Director, President and CEO
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$347K
90.4K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

14
BB
Bawel David BenjaminSVP & CHIEF ACCOUNTING OFFICER
DGICADONEGAL GROUP INC
Other acquisition or disposition
J$970
51 sh
Feb 17, 2026Feb 20, 2026
traded Feb 17, 2026
+3dSEC Form 4

Evidence

13
PR
Purdue David RyanSVP, Controller
ABBVAbbVie Inc.
Grant or award
A—
890 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
RA
Rodriguez AdrianSee remarks
AMTBAmerant Bancorp Inc.
Option exercise
M—
833 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
CN
Carol NutterSVP, Chief People Officer
CTEVClaritev Corp
Grant or award
A—
1,884 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
DL
Dietrich LisaEVP, CDIO
LECOLINCOLN ELECTRIC HOLDINGS INC
Grant or award
A—
513 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
SA
Sandler ArielChief Operations Officer
PLTKPlaytika Holding Corp.
Grant or award
A—
47.4K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

13
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$6,097
100 sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

13
VY
van der Laan YvonneEVP, Circular & Low Carbon Sol
LYBLyondellBasell Industries N.V.
Grant or award
A$45K
797 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
PR
Purdue David RyanSVP, Controller
ABBVAbbVie Inc.
Grant or award
A—
1,292 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Grant or award
A—
1,586 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
CD
Crum Demetris DEVP, CHIEF HR OFFICER
ABBVAbbVie Inc.
Grant or award
A—
1,244 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
TR
Thakkar RoopalEVP, R&D and CSO
ABBVAbbVie Inc.
Grant or award
A—
6,638 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence